Voice and Voice Affected Disorders Audiovisual Database


About this study

The purpose of this study is to develop a clinical and remotely accessible tool that automatically detects various human diseases using audiovisual data associated with human voice and speech.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Fluent in English (does not need an interpreter).
  • Able to give consent for self.

Exclusion Criteria: 

  • History of upper respiratory infection in the past month.
  • Vocal surgery or surgery targeted at altering vocal symptoms such as recurrent laryngeal nerve denervation renervation, Type I-IV thyroplasty, or deep brain stimulator. 
  • Botulinum toxin injection within 3 months (90days) of study enrollment.
  • Congenital or acquired hearing loss to the degree testing process is impaired. 
  • Subjects wearing hearing aids will be excluded from the speech in noise stressor task.
  • Severe comorbidities such as major depressive disorder or neurodegenerative disease will be excluded.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 1/27/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Diana Orbelo, Ph.D.

Open for enrollment

Contact information:

Ashlee Kirtz

(507) 284-1231


More information


Publications are currently not available